Results 201 to 210 of about 73,410 (327)

Clinical impact of pneumomediastinum in patients with myositis-associated interstitial lung disease

Junghee Jung, Min Jee Kim, Bin Yoo, Chang‐Keun Lee, Yong‐Gil Kim, Seokchan Hong, Soo Min Ahn, Ho Cheol Kim   +7 more
openalex   +1 more source

Orbital Myositis

, 2011
Toshinobu Kubota
openalex   +2 more sources

Metabarcoding Reveals a Potentially Undescribed Columnaris‐Causing Bacterium in Peracute Skin Disease of Rainbow Trout (Oncorhynchus mykiss, Walbaum)

Journal of Fish Diseases, Volume 49, Issue 1, January 2026.
ABSTRACT Columnaris‐causing bacteria (CCB) represent a group of four Flavobacterium species, previously classified under Flavobacterium columnaris, causing a threatening condition in salmonid farming characterised by cutaneous and gill lesions, commonly referred to as ‘saddleback disease’. A peracute skin disease outbreak with high mortality in rainbow
Samuele Zamparo, Ginevra Brocca, Fabio Marroni, Slobodanka Radovic, Ciro Castellano, Diana Torge, Serena Bianchi, David Groman, Guido Macchiarelli, Luisa Vera Muscatello, Donatella Volpatti, Massimo Orioles   +11 more
wiley   +1 more source

Association of serological markers and interstitial lung disease in patients with suspected myositis. [PDF]

Medicine (Baltimore)
Shi L, Wu Y, Fu J, Liu X, Wang P.
europepmc   +1 more source

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

Journal of Gastroenterology and Hepatology, Volume 41, Issue 1, Page 302-311, January 2026.
ABSTRACT Background and Aim Data on sequential immune checkpoint inhibitor (ICI) retreatment following initial atezolizumab plus bevacizumab (Atez + Bev) are limited. This study aimed to evaluate the efficacy and safety of sequential ICI retreatment in patients with unresectable hepatocellular carcinoma (uHCC). Methods Of 835 patients with uHCC treated
Takanori Ito, Shigeo Shimose, Issei Saeki, Yasuto Takeuchi, Joji Tani, Tetsu Tomonari, Ryu Sasaki, Kyo Sasaki, Satoru Kakizaki, Takeshi Hatanaka, Hideki Iwamoto, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Tomotake Shirono, Yuki Kanayama, Hisamitsu Miyaaki, Sohji Nishina, Tetsuji Takayama, Hideki Kobara, Motoyuki Otsuka, Taro Takami, Takumi Kawaguchi, Hiroki Kawashima, Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group   +24 more
wiley   +1 more source

Interferon regulatory factor 1 protects against chikungunya virus-induced immunopathology by restricting infection in muscle cells [PDF]

, 2017
Diamond, Michael S, Nair, Sharmila, Poddar, Subhajit, Shimak, Raeann M   +3 more
core   +2 more sources

Recurrent calf myositis as revealing manifestation of Crohn disease: a case report. [PDF]

Front Pediatr
La Rosa A, Meneghel A, Giraudo C, Zucchetta P, Tirelli F, Trevisan F, Calabrese F, Zulian F.   +7 more
europepmc   +1 more source

Unilateral myositis ossificans traumatica of medial pterygoid muscle: Case report and review

, 2019
Pinakapani Ramakrishna, Biswajit Mishra, Sanjay Jadwani, Seema Dengra   +3 more
openalex   +1 more source

Relationship Between Swallowing Frequency and Swallowing‐Related Muscle Mass in Older Adults

Journal of Oral Rehabilitation, Volume 53, Issue 1, Page 42-49, January 2026.
The relationship between swallowing frequency and geniohyoid muscles was investigated. We show the positive correlation between them. ABSTRACT Background Older adults have decreased swallowing‐related muscle mass, which may lead to decreased swallowing function.
Haruna Kawamichi, Aya Obana, Kanji Nohara, Nobukazu Tanaka, Takayoshi Sakai   +4 more
wiley   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source